The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor models
Durant, Stephen T., Zheng, Li, Wang, Yingchun, Chen, Kan, Zhang, Lingli, Zhang, Tianwei, Yang, Zhenfan, Riches, Lucy, Trinidad, Antonio G., Fok, Jacqueline H. L., Hunt, Tom, Pike, Kurt G., Wilson, JoaVolume:
4
Language:
english
Journal:
Science Advances
DOI:
10.1126/sciadv.aat1719
Date:
June, 2018
File:
PDF, 2.54 MB
english, 2018